"While tens of millions of Americans are experiencing extreme economic hardship and dealing with intermittent and often inadequate governmental support for unemployment, food, housing, and small business continuity," said Robert Weissman of Public Citizen on February 12, 2021, "Johnson & Johnson, McKesson, Cardinal Health, and Amerisource-Bergen are laughing all the way to bank." (Photo: Mark Ralston/AFP via Getty Images)
'Beyond Outrageous': Big Pharma Using Loophole to Get Taxpayers to Fund Billions in Fines for Fueling Opioid Crisis
"The tax code is so rigged for the rich that even when they kill people they get a tax break."
Four pharmaceutical corporations that agreed to pay a combined $26 billion to settle lawsuits resulting from a deadly opioid crisis they helped create reportedly plan to recoup a portion of those costs by deducting roughly $4.6 billion of the payouts from their taxes--sparking intense condemnation.
Big Pharma is attempting to make the public cover some of the fines related to lawsuits filed by dozens of state and local governments highlighting the culpability of opioid manufacturers and distributors in the deaths of an estimated 70,000 people per year.
As Public Citizen president Robert Weissman put it in a statement released Friday, "The drug companies are settling with taxpayers (local government entities) and then demanding that taxpayers pay part of the cost (via a federal tax subsidy)."
The Washington Post, which analyzed regulatory filings, reported Friday that "as details of the blockbuster settlement were still being worked out, pharmaceutical giant Johnson & Johnson and the 'big three' drug distributors--McKesson, AmerisourceBergen, and Cardinal Health--all updated their financial projections to include large tax benefits stemming from the expected deal."
Weissman called it "beyond outrageous for the drug makers and distributors to take a tax deduction for their settlement of city and county claims relating to the drug companies' alleged role in creating and worsening the opioid addiction epidemic."
"Making this scheme even more infuriating," he added, "is that the opioid manufacturer and distributor companies are preparing to claim billions in tax subsidies via a Covid-19 relief provision."
According to the Post, "U.S. tax laws generally restrict companies from deducting the cost of legal settlements from their taxes, with one major exception: Damages paid to victims as restitution for the misdeeds can usually be deducted."
The newspaper noted that "Congress has placed stricter limits on such deductions in recent years, and some tax experts say the Internal Revenue Service could challenge the companies' attempts to deduct opioid settlement costs."
But the ploy might work, as The Week noted, thanks to the CARES Act, which "opened up billions of dollars in tax breaks to companies regardless of pandemic suffering."
The Post provided an example of how one of the companies may exploit the loophole: "Dublin, Ohio-based drug distributor Cardinal Health said earlier this month it planned to collect a $974 million cash refund because it claimed its opioid-related legal costs as a 'net operating loss carryback'--a tax provision Congress included in last year's coronavirus bailout package as a way of helping companies struggling during the pandemic."
"Whether the payments will be deductible may hinge on specific word choices in the final terms of the settlement," the newspaper reported. "Though recent changes to the tax code have attempted to close loopholes that permit companies to deduct taxes when they have committed wrongdoing, many companies now push to make sure their settlements include a 'restitution' payment for victims--the 'magic word' that often qualifies them for deductions."
"Greg McNeil, whose son became addicted to opioids and died from an overdose... said $26 billion is only a small fraction of the epidemic's financial toll and argue[d] the proposal doesn't include what many family members of opioid victims want the most: an admission of guilt," the Post added.
Not only do "all four firms disavow any wrongdoing or legal responsibility," the Post noted, but there is now a chance that Big Pharma could make the public foot part of the bill for its corporate malpractice--in the midst of the devastating coronavirus pandemic.
"While tens of millions of Americans are experiencing extreme economic hardship and dealing with intermittent and often inadequate governmental support for unemployment, food, housing, and small business continuity," Weissman said, "Johnson & Johnson, McKesson, Cardinal Health, and Amerisource-Bergen are laughing all the way to bank."
Urgent. It's never been this bad.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission from the outset was simple. To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It’s never been this bad out there. And it’s never been this hard to keep us going. At the very moment Common Dreams is most needed and doing some of its best and most important work, the threats we face are intensifying. Right now, with just four days to go in our Spring Campaign, we are not even halfway to our goal. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Can you make a gift right now to make sure Common Dreams not only survives but thrives? There is no backup plan or rainy day fund. There is only you. —Craig Brown, Co-founder |
Four pharmaceutical corporations that agreed to pay a combined $26 billion to settle lawsuits resulting from a deadly opioid crisis they helped create reportedly plan to recoup a portion of those costs by deducting roughly $4.6 billion of the payouts from their taxes--sparking intense condemnation.
Big Pharma is attempting to make the public cover some of the fines related to lawsuits filed by dozens of state and local governments highlighting the culpability of opioid manufacturers and distributors in the deaths of an estimated 70,000 people per year.
As Public Citizen president Robert Weissman put it in a statement released Friday, "The drug companies are settling with taxpayers (local government entities) and then demanding that taxpayers pay part of the cost (via a federal tax subsidy)."
The Washington Post, which analyzed regulatory filings, reported Friday that "as details of the blockbuster settlement were still being worked out, pharmaceutical giant Johnson & Johnson and the 'big three' drug distributors--McKesson, AmerisourceBergen, and Cardinal Health--all updated their financial projections to include large tax benefits stemming from the expected deal."
Weissman called it "beyond outrageous for the drug makers and distributors to take a tax deduction for their settlement of city and county claims relating to the drug companies' alleged role in creating and worsening the opioid addiction epidemic."
"Making this scheme even more infuriating," he added, "is that the opioid manufacturer and distributor companies are preparing to claim billions in tax subsidies via a Covid-19 relief provision."
According to the Post, "U.S. tax laws generally restrict companies from deducting the cost of legal settlements from their taxes, with one major exception: Damages paid to victims as restitution for the misdeeds can usually be deducted."
The newspaper noted that "Congress has placed stricter limits on such deductions in recent years, and some tax experts say the Internal Revenue Service could challenge the companies' attempts to deduct opioid settlement costs."
But the ploy might work, as The Week noted, thanks to the CARES Act, which "opened up billions of dollars in tax breaks to companies regardless of pandemic suffering."
The Post provided an example of how one of the companies may exploit the loophole: "Dublin, Ohio-based drug distributor Cardinal Health said earlier this month it planned to collect a $974 million cash refund because it claimed its opioid-related legal costs as a 'net operating loss carryback'--a tax provision Congress included in last year's coronavirus bailout package as a way of helping companies struggling during the pandemic."
"Whether the payments will be deductible may hinge on specific word choices in the final terms of the settlement," the newspaper reported. "Though recent changes to the tax code have attempted to close loopholes that permit companies to deduct taxes when they have committed wrongdoing, many companies now push to make sure their settlements include a 'restitution' payment for victims--the 'magic word' that often qualifies them for deductions."
"Greg McNeil, whose son became addicted to opioids and died from an overdose... said $26 billion is only a small fraction of the epidemic's financial toll and argue[d] the proposal doesn't include what many family members of opioid victims want the most: an admission of guilt," the Post added.
Not only do "all four firms disavow any wrongdoing or legal responsibility," the Post noted, but there is now a chance that Big Pharma could make the public foot part of the bill for its corporate malpractice--in the midst of the devastating coronavirus pandemic.
"While tens of millions of Americans are experiencing extreme economic hardship and dealing with intermittent and often inadequate governmental support for unemployment, food, housing, and small business continuity," Weissman said, "Johnson & Johnson, McKesson, Cardinal Health, and Amerisource-Bergen are laughing all the way to bank."
Four pharmaceutical corporations that agreed to pay a combined $26 billion to settle lawsuits resulting from a deadly opioid crisis they helped create reportedly plan to recoup a portion of those costs by deducting roughly $4.6 billion of the payouts from their taxes--sparking intense condemnation.
Big Pharma is attempting to make the public cover some of the fines related to lawsuits filed by dozens of state and local governments highlighting the culpability of opioid manufacturers and distributors in the deaths of an estimated 70,000 people per year.
As Public Citizen president Robert Weissman put it in a statement released Friday, "The drug companies are settling with taxpayers (local government entities) and then demanding that taxpayers pay part of the cost (via a federal tax subsidy)."
The Washington Post, which analyzed regulatory filings, reported Friday that "as details of the blockbuster settlement were still being worked out, pharmaceutical giant Johnson & Johnson and the 'big three' drug distributors--McKesson, AmerisourceBergen, and Cardinal Health--all updated their financial projections to include large tax benefits stemming from the expected deal."
Weissman called it "beyond outrageous for the drug makers and distributors to take a tax deduction for their settlement of city and county claims relating to the drug companies' alleged role in creating and worsening the opioid addiction epidemic."
"Making this scheme even more infuriating," he added, "is that the opioid manufacturer and distributor companies are preparing to claim billions in tax subsidies via a Covid-19 relief provision."
According to the Post, "U.S. tax laws generally restrict companies from deducting the cost of legal settlements from their taxes, with one major exception: Damages paid to victims as restitution for the misdeeds can usually be deducted."
The newspaper noted that "Congress has placed stricter limits on such deductions in recent years, and some tax experts say the Internal Revenue Service could challenge the companies' attempts to deduct opioid settlement costs."
But the ploy might work, as The Week noted, thanks to the CARES Act, which "opened up billions of dollars in tax breaks to companies regardless of pandemic suffering."
The Post provided an example of how one of the companies may exploit the loophole: "Dublin, Ohio-based drug distributor Cardinal Health said earlier this month it planned to collect a $974 million cash refund because it claimed its opioid-related legal costs as a 'net operating loss carryback'--a tax provision Congress included in last year's coronavirus bailout package as a way of helping companies struggling during the pandemic."
"Whether the payments will be deductible may hinge on specific word choices in the final terms of the settlement," the newspaper reported. "Though recent changes to the tax code have attempted to close loopholes that permit companies to deduct taxes when they have committed wrongdoing, many companies now push to make sure their settlements include a 'restitution' payment for victims--the 'magic word' that often qualifies them for deductions."
"Greg McNeil, whose son became addicted to opioids and died from an overdose... said $26 billion is only a small fraction of the epidemic's financial toll and argue[d] the proposal doesn't include what many family members of opioid victims want the most: an admission of guilt," the Post added.
Not only do "all four firms disavow any wrongdoing or legal responsibility," the Post noted, but there is now a chance that Big Pharma could make the public foot part of the bill for its corporate malpractice--in the midst of the devastating coronavirus pandemic.
"While tens of millions of Americans are experiencing extreme economic hardship and dealing with intermittent and often inadequate governmental support for unemployment, food, housing, and small business continuity," Weissman said, "Johnson & Johnson, McKesson, Cardinal Health, and Amerisource-Bergen are laughing all the way to bank."